Home › Non-Small Cell Lung Cancer › Florida › Deltona
Non-Small Cell Lung Cancer clinical trials in Deltona, FL
15 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Deltona (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RecruitingPhase 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · 4 mi away
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RecruitingPhase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Alpha Clinical Research Centers LLC, Orange City · 4 mi away
- Florida Cancer Specialists, Orange City · 4 mi away
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
- and 1 more
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RecruitingPhase 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · 4 mi away
Pan-tumor MRD Study
RecruitingObservational study
- Mid Florida Cancer Centers, Orange City · 4 mi away
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RecruitingPhase 3
- Research Site, Orange City · 4 mi away
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RecruitingPhase 2/3
- Mid Florida Cancer Centers, Orange City · 4 mi away
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RecruitingPhase 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
RecruitingPhase 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- Local Institution - 007-926-B, Daytona Beach · 26 mi away
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RecruitingPhase 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · 4 mi away
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 3
- Research Site, Orange City · 4 mi away
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RecruitingPhase 2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN96 studies
- Boston, MA89 studies
- Los Angeles, CA87 studies
- St. Louis, MO71 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH55 studies
- Washington, DC54 studies
Other studies in Deltona
- Obesity11 studies
- Type 2 Diabetes10 studies
- Alzheimer's Disease10 studies
- Overweight9 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Cancer (all types)7 studies
- Metastatic Cancer5 studies
- High Blood Pressure5 studies
- Knee Osteoarthritis5 studies
- Melanoma5 studies
- Cholesterol4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.